Ovid Therapeutics Inc. Common Stock (OVID) is a publicly traded Healthcare sector company. As of July 8, 2026, OVID trades at $2.56 with a market cap of $487.13M and a P/E ratio of 0.00. OVID moved -7.25% today. Year to date, OVID is +69.33%; over the trailing twelve months it is +637.97%. Its 52-week range spans $0.24 to $3.11. Analyst consensus is strong buy with an average price target of $5.60. Rallies surfaces OVID's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for OVID, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $2.56 |
| Market Cap | $487.13M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.11 |
| 52-Week Low | $0.24 |
| Volume | 552.01K |
| Avg Volume | 0 |
| Revenue (TTM) | $7.12M |
| Net Income | $-24.17M |
| Gross Margin | 0.00% |
7 analysts cover OVID: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.60.